Fedrigoni and Palantir Partner to Accelerate Operational Transformation with AI
Palantir Technologies Inc. (NASDAQ: PLTR) today announced a multi-year partnership with Fedrigoni, a global reference manufacturer of specialty papers for packaging and other creative applications, self-adhesive labels, graphic supports for visual communication, and RFID. This strategic alliance aims to accelerate Fedrigoni's digital transformation by leveraging advanced AI capabilities and Palantir's innovative solutions. Initially focused on stock optimization and demand forecasting, the partnership is now expanding to support Fedrigoni's comprehensive digital transformation objectives.
The collaboration between Fedrigoni and Palantir represents a pivotal step in enhancing operational efficiency and driving innovation across Fedrigoni's global operations. By utilizing Palantir's cutting-edge AI technology, Fedrigoni seeks to improve its responsiveness to market dynamics and enhance its ability to anticipate and meet customer demands. Fedrigoni is advised on this project by Avatar Investments, a preferred Partner of Palantir in Italy.
"We are delighted to deepen our partnership with Palantir as we embark on this transformative journey," stated Marco Nespolo, CEO of Fedrigoni. "Our collaboration with Palantir will enable us to harness the power of AI to be increasingly agile and competitive in a rapidly evolving market. This partnership is a critical component of our strategy to lead the industry in operational excellence and customer service." Gionata Berna, CIO of Fedrigoni, also emphasized the strategic importance of the partnership: "Integrating Palantir's AI solutions into our operations signifies a major advancement in our digital innovation strategy. The ability to accurately forecast demand and optimize stock levels is just the beginning. We are committed to building a data-driven organization that can swiftly adapt to changes and capitalize on new opportunities."
Palantir's Managing Director for Palantir France and EMEA Executive, François Bohuon, expressed enthusiasm for the partnership: "We are excited to collaborate with Fedrigoni on their digital transformation journey. This partnership highlights the transformative potential of AI in traditional industries, and we are honored to support Fedrigoni in achieving their strategic vision. Our technology will empower them to unlock new efficiencies and drive growth." Guillaume Soule, EMEA Manufacturing AI Lead at Palantir, added, "Fedrigoni's forward-thinking approach to digital transformation aligns perfectly with our mission to empower organizations through data-driven insights. By leveraging AI, we are poised to deliver impactful results that will enable Fedrigoni to enhance its operational capabilities and achieve sustained success."
This partnership underscores the growing importance of digital transformation in traditional manufacturing sectors and highlights the role of AI in driving innovation and efficiency. Both companies are committed to a collaborative approach that will deliver breakthrough solutions and create long-term value.
About Palantir Technologies Inc.
Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com.
About Fedrigoni
Founded in 1888 in Verona, Fedrigoni is today the global leader in specialty papers for luxury packaging and premium labels for wines, the third player in the self-adhesive materials market and RFID inlay production, and the second in art and drawing papers with Fabriano brand. With nearly 6,000 people in 28 countries and 74 plants including production sites, cutting and distribution centers, the Group sells and distributes over 25,000 products in 132 countries. For more information: www.fedrigoni.com
About Avatar Investments
Founded in 2024 by Ludovico Fassati and Riccardo Basile, Avatar is helping companies achieve their full potential using the latest AI technologies. Avatar has a unique approach melting consulting with investing. For more information: www.avatar-investments.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond Palantir's control. These risks and uncertainties include the ability to meet the unique needs of customers; the failure of Palantir's platforms to satisfy customers or perform as desired; the frequency or severity of any software and implementation errors; Palantir's platforms’ reliability; and customers' ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings Palantir makes with the Securities and Exchange Commission from time to time. Except as required by law, Palantir does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610466164/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release
POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 21:30:00 CEST | Press release
Progress in natural refrigerants, water efficiency and circular economy underscores Güntner’s global impact Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal,
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 20:45:00 CEST | Press release
Windsurf launches a GPU cluster in Germany, delivering 50% faster performance and secure access to European enterprises. Data residency ensures enterprise repositories stay within the EU, meeting stringent security requirements. Windsurf already supports 100+ European enterprise customers, highlighting strong demand for AI-powered development tools across EMEA. Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 19:00:00 CEST | Press release
New SDK Integration Simplifies Monetization for Defold Developers Publishing on CrazyGames Ahead of Global Game Jam Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization jou
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom